chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sharp pain in right lung which became unbearable when trying to take a deep breath or yawn.  Started mild grew extremely painful over the next couple of days. Given her a lidocaine patch at the hospital told to take Tylenol and ibuprofen. That made the pain bearable as it slowly went away over the next few days. I have no reason to suspect it was Covid related. I tested negative for Covid.  It has been four months since I had my Moderna booster.
This spontaneous report was received from a registered nurse via a company representative referring to a male patient of "70ish year old". The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (route, dose, dose number, lot number, expiration date and frequency were not provided). The reporter also stated that the patient did not receive the vaccine from his primary care physician and it was unknown where he received the ZOSTAVAX. Concomitant medications were not reported. On an unknown date, the patient experienced herpes zoster with long lasting pain while he was in a nursing home. The patient sought medical attention on an unknown date and in a unspecified way. However, there was no intervention to prevent serious criteria. There was no product quality complaint (PQC) involved. The outcome of herpes zoster was reported as not recovered. The primary reporter did not provide the causal relationship between ZOSTAVAX and the event. Additional information has been requested.
Had the vaccine/ Has had shingles twice after the shot/Suspected vaccination failure; She has had shingles twice after the shot; She has had shingles twice after the shot; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and shingles. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  This case was reported by patient's daughter/son.                                       The age at vaccination was not reported. The patient had the Shingle vaccine and so far she has had shingles twice after the shot. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
pt recv vax; redness, firmness, inc warmth, tenderness at inject site & surrounding area approx 3x3";
I went to my doctor for a check up with the blood test it showed I was anemic. I was told to go to a hematologist who put me on a regiment five iron infusions starting 12JAN2023 with no improvement. I went to a Gastroenterologist who sent me have an endoscopy, colonoscopy and a CAT Scan, a diagnosis of a mass in my right colon was diagnosed. On 28FEB2023 a Colectomy was performed and the mass removed.
very sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was not recovered/not resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were reported as follows: Age at vaccination was not reported. The patient received a dose of Shingles vaccine on an unknown date and experienced Sickness. The patient had to get monthly transfusions to counteract the damage but it did not work for her. The patient was still suffering from the adverse event. Consent to follow up was possible as contact details were not available.
pt recv vax;stated "hurting";small reddened area;next am T 99.2PO;no redness/swelling;apap for HA;arm soreness;large 5"x4"; long reddened indurated area;no bruising; advised to cont apap & ice pack;
This spontaneous report was received from a health care professional refers to unspecified patients of unknown demographics. Approximately in 2016 (also reported as "unspecified dates since 09-FEB-2016") the patients were vaccinated with improperly stored VARIVAX (Merck) (dosing regimen unspecified) (L034372/ expiry. 08-SEP-2017; L011083/ expiry. 01-APR-2017; K002927/ expiry. 26-FEB-2016; K008824/ expiry. 19-JUN-2016). This request was originally opened on 09-FEB-2016 to evaluate improperly stored vaccines. The healthcare worker called back to evaluate the same doses, which were previously exposed to temperatures outside of the recommended range, and had been administered to patients since this service request was opened. Healthcare worker reported that doses of the following, which were exposed to the following conditions, were administered to unspecified patients: temperature: -10.96C, Time frame: 15 hours, previous temperature excursion: -11.51C for 15 hours. It was not a call because of a data logger. No additional information was provided. This is one of the two reports from the same reporter. Additional information has been requested.
Patient received covid-19 vaccine at off-site clinic. As she was walking up to the post vaccination waiting area after receiving the vaccine, she suffered what appeared to be an anxiety attack and fainted. She awoke quickly and was monitored by pharmacy staff. She maintained good blood pressure and was fine afterwards.
OFF BALANCE; STOMACH PAINS; BOILING STOMACH (FELT LIKE HEARTBURN); NAUSEA; This spontaneous report received from a patient concerned a 26 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, expiry: Unknown) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-MAY-2021, the subject experienced off balance. On 27-MAY-2021, the subject experienced stomach pains. On 27-MAY-2021, the subject experienced boiling stomach (felt like heartburn). On 27-MAY-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nausea, off balance, stomach pains, and boiling stomach (felt like heartburn). This report was non-serious.
Moderna COVID-19 Vaccine EUA: Rash on upper arm around the injection site. Very warm to the touch and itchy.
Large, red, pruritic area of edema 2-3 days after immunization received DtaP and IPV in that leg.
Narrative:  Pt reported no reaction until 4 days after 1st moderna vaccine including erythema and pruritis that lasted for five days and stopped. He is without symptoms today upon return for his second vaccine dose.
3 days following the first dose of the Shingrix shot I came down with a rash.  A physician confirmed the rash was a result of having shingles 3 days after that.  It is a very painful rash just under my right breast.  I had also taken thee original shingles shot a couple of years prior. A month before taking the Shingrix shot, I had a flu shot. I never had shingles prior to this and I have not had the flu in a number of years; I always get that shot. I am currently taking Gapapentin and Acyclovir 400MG.  This is my first day of medication.
upper right arm pain/soreness (5-days); headache (3-days); low grade fever (2-days); bodyaches (2-days); nausea (5-days); extreme abdominal bloating (6-days);   vomiting (day 3-one episode); diahrrea beginning day 3-4-5/times/day--ended day 5 transitioned to current soft bowel movements 1-3/times/day; continued abdominal bloating-less severe;flatulence; ongoing extreme fatigue since day of vaccine
Patient received a rash on arm just below site of injection 3 days after injection.  It was warm to the touch no pain or itch. No medications or treatments were pursued, just observation.  The rash resolved spontaneously by the 4th day.
Itchy, swollen, red, and warm hive about 3 inches in diameter at the injection site.
This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 68-year-old female patient who received SHINGRIX for prophylaxis. The patient's past medical history included pneumonia. Concurrent medical conditions included cervical dystonia. On 7th March 2019, the patient received the 2nd dose of SHINGRIX. On 8th March 2019, 1 days after receiving SHINGRIX, the patient experienced dizziness, sore eye, muscle pain, injection site pain, nausea, headache, fatigue, neck pain and condition aggravated. On 12th March 2019, the patient experienced hoarse voice. On 13th March 2019, the patient experienced dry mouth. On an unknown date, the outcome of the dizziness, sore eye, muscle pain, injection site pain, nausea, dry mouth, hoarse voice, headache, fatigue, neck pain and condition aggravated were not recovered/not resolved. It was unknown if the reporter considered the dizziness, sore eye, muscle pain, injection site pain, nausea, dry mouth, hoarse voice, headache, fatigue, neck pain and condition aggravated to be related to SHINGRIX. Additional details were provided as follows: The patient had a history of cervical dystonia. On 7th March 2019, the patient received SHINGRIX on left arm. The patient experienced all of the side effects the day after receiving the injection. The patient had arm pain at the injection site and also pain in the right side of her neck. The patient thought that the neck pain may be a flare up of cervical dystonia condition. The headache lasted three days and resolved, but come back. All other symptoms also resolved but re-occurred. The dizziness was the worst and that had not resolved at all. The reporter consented to follow up. Discrepancy: TTO for the events dry mouth and hoarse voice had been autocalculated as per the event onset date reported in source document, whereas narrative stated that all the events occurred the day after receiving the injection.
4/16/21 0300 102.2 fever and chills duration 17 hours 4/16/21 1300 headache, body aches, fatigue, nausea, vertigo- not resolved as of submission of adverse events 4/16/21 2000
A 53-yo male patient with a nonsignificant past medical history presented to the hospital with worsening generalized muscle pain, and weakness. Patient reported that he received the Jannsen COVID-19 vaccine 3 weeks prior to admission and symptoms began 8 days later. On the morning of admission the patient also developed pressure-like and pleuritic chest pain.  EKG findings showed ST elevations in V5-V6 with depression in aVL.  D-dimer was found to be elevated however PE evaluation was negative.  Troponins were also found to be elevated. The patient was diagnosed with acute pericarditis and underwent left heart catheterization, selective coronary angiography and left ventriculography. The coronary angiography revealed no significant obstructive coronary artery disease, and left ventriculography revealed normal LV size and function.  Patient was subsequently initiated on colchicine therapy for acute pericarditis. He remains admitted at hospital.
Patient complained of swelling in her left and right wrist. No severe pain was exhibited. She said it happened later that afternoon. The patient notified me she was already taking a steroid (unknown) and did not have a really bad reaction. She spoke to her physician about the reaction and the physician told her to take Benadryl and Tylenol before the next shot. The patient does still want to receive the second dose when it is time.
Second Moderna dose given too early, first dose given on 12/19/22 second given 1/11/23 (requires 28 days between doses).  Dose will need to be repeated in 28 days.
After the second dose of the Moderna Covid19 vaccination, I had a fever and chills and felt like I had the flu. Two days after the second dose of the Moderna Covid19 vaccination I felt like my internal organs were being pulled down/out, there was pain in my pelvic area and slight bleeding, even though I am in menopause.  There was pain during intercourse that eventually made intercourse impossible. I went to an OB and she referred me to clinic for physical therapy. At clinic they determined that my pelvic floor had spasmed and it was pulling my cervix to one side and causing the pain I was experiencing. They felt there was a high likelihood that it was caused by the vaccine. I received 8 physical therapy treatments and most of my pain is gone but I still experience some pain with intercourse.
It was reported that a male patient in his 40's received a Fluzone SV vaccination on 11/15/2000. Reportedly within 24 hours, the patient had flu-like symptoms and fever blisters on his lip and the septum of his nose. The symptoms resolved in a few days. From additional correspondence received on 02/28/2001, additional patient, vaccine administrator and responsible physician information were provided. No further information is anticipated. This case is closed.
Death due to Acute Coronary Insufficiency due to Acute Thrombus in the Left Descending Coronary Artery
pt recv vax 19APR97 & fever started 8PM 20APR97 101.1;given APAP;fever on 21APR97 101.3 & shaking jerking movement remained conscious & talking;then sleepy;dx febrile sz seen by MD also dx lt OM;
Within 24 hours post vax, the pt developed redness and tenderness at the injection site. 48 hours after the injection she experienced malaise. She reports that her diverticulitis got better following the injection but now has worsened.
I started having difficulty swallowing my prenatal pills. Still breast feeding. I would cough them up because I was unable to swallow. Stopped taking them. After a couple months I went to ENT and ordered swallow study and noted the pill got hung up at top of esophagus. Referred to GI and did upper endoscopy in December. Esophagus was inflamed.  eosinophilic esophagitis (cell count 175 normal is 0-5) autoimmune disorder. Now on medications to help with inflammation. April reports show inflammation down. Unsure what triggered all of this. Tested negative for food allergies. Working with other doctor for other allergies.
Information has been received from a pharmacist concerning a patient who on 18-FEB-2008 was vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # reported as 0047X). On 18-FEB-2008, the patient developed a "welt" at the injection site. As of the time of this report, the patient's welt at injection site persisted. No additional information was provided. Additional information has been requested.
This case was reported by a physician via sales rep and described the occurrence of influenza-like symptoms in a adult patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: This case was reported by the physician for his staff member. The age at vaccination was not reported. The age group was not reported but was captured adult as per vaccine indication. The patient experienced flu like symptoms which impacted the patient for a few days. The reporter did not agree to be followed up. This is 1 of the 6 cases reported by same reporter.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 28Dec2021 as dose 3 (booster), single (Lot number: 3020308D) at the age of 55 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Heart condition" (unspecified if ongoing), notes: other medical history Heart condition. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: Rebound with covid 4 days after taking my final dose. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: Patient received other medication in 2 weeks is reported as no. The patient received COVID 19 Treatment Paxlovid from 24May2022 to 28May2022 (GA8204) for the treatment of COVID-19. Adverse event: Rebound with covid 4 days after taking my final dose of paxlovid.  No follow-up attempts are possible. No further information is expected.
Middle ear muscle myoclonus; tinnitus/loud buzzing in right ear/ringing; inflammation/vaccination caused inflammation/believe i have auditory nerve inflammation; sharp pain in my ears/Ear pain; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (sharp pain in my ears/Ear pain), TINNITUS (tinnitus/loud buzzing in right ear/ringing), INFLAMMATION (inflammation/vaccination caused inflammation/believe i have auditory nerve inflammation) and MYOCLONUS (Middle ear muscle myoclonus) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     Concurrent medical conditions included Poison ivy rash (treatment drug Prednisone from 22-Apr-2021 to 02-May-2021) since 22-Apr-2021.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced EAR PAIN (sharp pain in my ears/Ear pain). On 23-Apr-2021, the patient experienced TINNITUS (tinnitus/loud buzzing in right ear/ringing) and INFLAMMATION (inflammation/vaccination caused inflammation/believe i have auditory nerve inflammation). On 08-Nov-2021, the patient experienced MYOCLONUS (Middle ear muscle myoclonus). The patient was treated with IVERMECTIN on 26-Sep-2021 for Inflammation, at an unspecified dose and frequency; VITAMINS NOS at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) on 15-Jul-2021 for Inflammation, at an unspecified dose and frequency; MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) on 03-Aug-2021 for Inflammation, at an unspecified dose and frequency; CALCIUM on 08-Nov-2021 for Myoclonus, at an unspecified dose and frequency and POTASSIUM on 08-Nov-2021 for Myoclonus, at an unspecified dose and frequency. At the time of the report, EAR PAIN (sharp pain in my ears/Ear pain) had resolved, TINNITUS (tinnitus/loud buzzing in right ear/ringing) had not resolved and INFLAMMATION (inflammation/vaccination caused inflammation/believe i have auditory nerve inflammation) and MYOCLONUS (Middle ear muscle myoclonus) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2021, Acoustic stimulation tests: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient states before vaccination patient didn't have any ear problem , allergies, tinnitus and  anxiety. On 3rd may 2021 patient field a report with VAERS.  Recently, patient did a hearing test and result said patient has normal hearing  Concomitant product was not provided by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 20-Nov-2021: Follow-up information included Patient details, Allergy, lab data,  treatment drugs, new event and its outcome.
administer expired vaccine to 450 patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to 450 patients, after the manufacture date of expiration) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to 450 patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to 450 patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Date the vial was initially stored in the refrigerator reported as unknown and the vial did not undergo any temperature excursions. The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live follow-up: Non-Significant: Reporter address updated.
staring episodes w/tonic movements noticed on 3 seperate occasions, onset 10FEB93;
Received the J&J vaccine at the facility on 8/04/2021. Two weeks after and in continuum, periods of breathing difficulties. Shallow breaths, shortness of breath, having to 'catch my breath' several times during the day. I've never had any upper respiratory issues, active, work out and no serious health issues.
She started feeling pain the next day after vaccine. Ever since  the vaccine she is in excruciating pain. The pain is in her upper body and flows to the hands and fingers on both sides of her body. Her wrist and fingers go numb, she can no longer dress herself without assistance. She went to the the hospital twice on 9/20/20219 and 10/8/2019. Both hospital visits she received Tordal shots for the pain but it did not help her at all. She feels pain like  she tore a tendon on the site of injection. She has no visible marks on the site of infection.  On 10/19/2019 she woke up in the middle of the night not being able to breathe.
Subsequent to receiving Tetanus and Diphtheria Toxoids Adsorbed Purogenated pt developed an injection site reaction.
Fever (36+hrs), nauseau (a little over 24 hours), dizziness (started about 24 hours after), sore arm (4 days) Treatment: orange juice, sleep, shower, water
approx 8mos p/vax pt began c/o soreness in rt knee early march, end of march apparent swelling & unable to walk. dx early may pauciarticular juvenile rheumatoid arthritis. prescribed naprosyn daily.
Patient was supposed to receive the 2nd dose of Pfizer vaccine but instead the pharmacist on duty administered a diluted dose of varicella vaccine to the patient.   Patient is showing no adverse effects at this time and has been contacted by 2 members of the staff thus far (myself and the district manager).  Follow up calls will take place to ensure this patient's safety.